Dogwood Therapeutics, Inc. (DWTX) vs NOMAD Power Solutions, Inc. (NMAD)
A side-by-side comparison of Dogwood Therapeutics, Inc. and NOMAD Power Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DWTX
Dogwood Therapeutics, Inc.
$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NMAD
NOMAD Power Solutions, Inc.
$4.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DWTX vs NMAD
growth of $100 · dividends reinvested · last 1yDWTX +4.1% (+4.1%/yr)NMAD -39.7% (-39.7%/yr)DWTX compounded faster over this window
DWTX NMAD
DWTX vs NMAD: by the numbers
- •NMAD is the larger company ($54M vs $51M market cap).
Metrics side by side
Valuation
| Metric | DWTX | NMAD |
|---|---|---|
| P/B ratio | 0.75 | 2245.98 |
Profitability
| Metric | DWTX | NMAD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -52.72% | -36114.03% |
| ROIC | -38.04% | -31665.34% |
Growth (annualized)
| Metric | DWTX | NMAD |
|---|---|---|
| Total return CAGR (5Y) | -58.44% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.